Viewing Study NCT04832204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-02-03 @ 2:56 AM
Study NCT ID: NCT04832204
Status: UNKNOWN
Last Update Posted: 2021-04-05
First Post: 2021-04-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Sponsor: Beijing Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None After first-line treatment failed View
None only liver metastases View